Latest

Antineoplastic agents

Revolutionary Approach to Anticancer Drug Sensitivity Prediction

Investigations at Genentech Inc. in South San Francisco, California, have led to the development of a groundbreaking computational procedure, REFINED, which significantly enhances predictive performance in anticancer drug sensitivity prediction tasks. This innovative methodology maps high-dimensional feature vectors into compact 2D images, enabling the application of convolutional neural networks (CNNs)